Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dicloxacillin to prevent exit site infection after tunneled cuffed catheter insertion in hemodialysis patients
TCTR20181001004Phase 3Recruiting
- Sponsor
- Chiang Mai Ram Medical Business
- Start
- Jun 2018
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dicloxacillin in Catheter exit site infection (ESI), sponsored by Chiang Mai Ram Medical Business. Started Jun 2018; status: recruiting.
02
Drugs
dicloxacillin
03
Conditions
Catheter exit site infection (ESI)
Beyond the preview
Go deeper on TCTR20181001004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20181001004.